Tag: Dance Biopharm

Industry Focus Areas, Medical

Dance Biopharm raises $24m for inhaled insulin device

September 25, 2018

Via: Mass Device

Privately-held Dance Biopharm said yesterday that it raised $24.5 million in a private equity round to help fund the development of its inhaled insulin product. SternAegis Ventures was the exclusive placement agent for the offering. Molex Ventures, an electronics company […]